English

GENOMIC HEALTH, INC.

EDGAR

GHDX Current report (8-K) · filed 2019-11-08

69 filing records in this dataset, filed from 2005-11-14 to 2019-11-08. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

105 million Unit12

2018 Q4 · Unit12

Exact inputs and evidence

Revenue: 104609000 Unit12 Source

Operating margin

9.01%

2018 Q4 · %

Exact inputs and evidence

Operating Income: 23896000 Unit12 Source
Operating Income: 14470000 Unit12 Source
Revenue: 104609000 Unit12 Source

Operating cash flow

24.6 million Unit12

2018 Q4 · Unit12

Exact inputs and evidence

Operating Cash Flow: 76562000 Unit12 Source
Operating Cash Flow: 51986000 Unit12 Source

Free cash flow

21.5 million Unit12

2018 Q4 · Unit12

Exact inputs and evidence

Operating Cash Flow: 76562000 Unit12 Source
Operating Cash Flow: 51986000 Unit12 Source
Capital Expenditure: 10076000 Unit12 Source
Capital Expenditure: 6953000 Unit12 Source

Cash and cash equivalents: 72 million Unit_Standard_USD_1VJC3oBlL0qhjUr57Gxxkg 2019-09-30 Source
Exact value

71961000 Unit_Standard_USD_1VJC3oBlL0qhjUr57Gxxkg
Long-term debt including current maturities: Not available
Shares outstanding: 36.4 million Unit1 2018-12-31 Source
Exact value

36407287 Unit1

Reported share-count change

3.87% · 1.36 million Unit1

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

35049436 Unit1 · 2017-12-31· Source
36407287 Unit1 · 2018-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2019-11-08.

Financial data available through: 2017-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2017-12-31
Operating income: 6 of 11 periods available· newest 2017-12-31
Net income: 3 of 11 periods available· newest 2017-12-31
Operating cash flow: 6 of 11 periods available· newest 2017-12-31
Capital expenditure: 6 of 11 periods available· newest 2017-12-31
Total assets: 5 of 11 periods available· newest 2017-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 2017-12-31
Current liabilities: 5 of 11 periods available· newest 2017-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2017-12-31
long term debt: No compatible figures in this window
Shares outstanding: 5 of 11 periods available· newest 2017-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+3.9%

Prior period

Unit12 327.87 million

2016-01-01 – 2016-12-31
Current period

Unit12 340.75 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

340750000 − 327868000 = 12882000 Unit12

327868000 Unit12 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
340750000 Unit12 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GENOMIC HEALTH, INC. · 2017-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Year-over-year change in Revenue: 12882000 Unit12 Concept: fundies:Revenue Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 340750000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837018002061/ghdx-20171231.xml#1476463 Filing: 000155837018002061 Input fundies:Revenue: 327868000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837018002061/ghdx-20171231.xml#1475496 Filing: 000155837018002061
The citation records this snapshot. The page link may show a newer release later.
Net income
+Unit12 10.06 million

Prior period

−Unit12 13.92 million

2016-01-01 – 2016-12-31
Current period

−Unit12 3.86 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-3857000 − -13919000 = 10062000 Unit12

-13919000 Unit12 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-3857000 Unit12 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GENOMIC HEALTH, INC. · 2017-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Year-over-year change in Net income: 10062000 Unit12 Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3857000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1558655 Filing: 000155837019001300 Input fundies:NetIncome: -13919000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1557916 Filing: 000155837019001300
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+127.5%

Prior period

Unit12 13.45 million

2016-01-01 – 2016-12-31
Current period

Unit12 30.6 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

30602000 − 13450000 = 17152000 Unit12

13450000 Unit12 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
30602000 Unit12 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GENOMIC HEALTH, INC. · 2017-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Year-over-year change in Operating cash flow: 17152000 Unit12 Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 30602000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1557262 Filing: 000155837019001300 Input fundies:OperatingCashFlow: 13450000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1557070 Filing: 000155837019001300
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-32.9%

Prior period

Unit12 19.79 million

2016-01-01 – 2016-12-31
Current period

Unit12 13.28 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

13276000 − 19786000 = -6510000 Unit12

19786000 Unit12 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
13276000 Unit12 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GENOMIC HEALTH, INC. · 2017-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Year-over-year change in Capital expenditure: -6510000 Unit12 Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13276000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1648130 Filing: 000155837019001300 Input fundies:CapitalExpenditure: 19786000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1647938 Filing: 000155837019001300
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2017-01-01 – 2017-12-31

Revenue Unit12 340.75 million 100% of revenue
Operating costs Derived Unit12 347.2 million 102% of revenue
Operating income −Unit12 6.45 million −1.9% of revenue
Tax, interest and other Derived −Unit12 2.59 million −0.8% of revenue
Net income −Unit12 3.86 million −1.1% of revenue

Cash

Operating cash flow Unit12 30.6 million 9% of revenue
Capital expenditure Unit12 13.28 million 3.9% of revenue
Free cash flow Derived Unit12 17.33 million 5.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2015 Operating loss: operating costs were 112% of revenue.
2016 Operating loss: operating costs were 105% of revenue.
2017 Operating loss: operating costs were 102% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2012 2012-01-01 – 2012-12-31	235173000	226739000 Derived	8434000	Unavailable	Unavailable	15906000 Derived	Source 2012-01-01 – 2012-12-31: 235173000 Unit12 Inspect Revenue Open source 2012-01-01 – 2012-12-31: 8434000 Unit12 Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 25962000 Unit12 Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 10056000 Unit12 Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	261595000	273427000 Derived	-11832000	Unavailable	Unavailable	-2456000 Derived	Source 2013-01-01 – 2013-12-31: 261595000 Unit12 Inspect Revenue Open source 2013-01-01 – 2013-12-31: -11832000 Unit12 Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 8552000 Unit12 Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 11008000 Unit12 Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	275706000	299333000 Derived	-23627000	Unavailable	Unavailable	-8168000 Derived	Source 2014-01-01 – 2014-12-31: 275706000 Unit12 Inspect Revenue Open source 2014-01-01 – 2014-12-31: -23627000 Unit12 Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 2287000 Unit12 Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 10455000 Unit12 Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	287458000	321485000 Derived	-34027000	-719000 Derived	-33308000	-35314000 Derived	Source 2015-01-01 – 2015-12-31: 287458000 Unit12 Inspect Revenue Open source 2015-01-01 – 2015-12-31: -34027000 Unit12 Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -33308000 Unit12 Inspect Net Income Open source 2015-01-01 – 2015-12-31: -11831000 Unit12 Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 23483000 Unit12 Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	327868000	343300000 Derived	-15432000	-1513000 Derived	-13919000	-6336000 Derived	Source 2016-01-01 – 2016-12-31: 327868000 Unit12 Inspect Revenue Open source 2016-01-01 – 2016-12-31: -15432000 Unit12 Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -13919000 Unit12 Inspect Net Income Open source 2016-01-01 – 2016-12-31: 13450000 Unit12 Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 19786000 Unit12 Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	340750000	347200000 Derived	-6450000	-2593000 Derived	-3857000	17326000 Derived	Source 2017-01-01 – 2017-12-31: 340750000 Unit12 Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6450000 Unit12 Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -3857000 Unit12 Inspect Net Income Open source 2017-01-01 – 2017-12-31: 30602000 Unit12 Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 13276000 Unit12 Inspect Capital Expenditure Open source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 340.8M 2017

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit12)	Source evidence
20122012-12-31	Revenue	235173000	Revenue: 235173000 Open source
20132013-12-31	Revenue	261595000	Revenue: 261595000 Open source
20142014-12-31	Revenue	275706000	Revenue: 275706000 Open source
20152015-12-31	Revenue	287458000	Revenue: 287458000 Open source
20162016-12-31	Revenue	327868000	Revenue: 327868000 Open source
20172017-12-31	Revenue	340750000	Revenue: 340750000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

3.9% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Year over year	No prior comparable period	Revenue: 235173000 Open source
20132013-12-31	Year over year	11.2%	Revenue: 261595000 Open source Revenue: 235173000 Open source
20142014-12-31	Year over year	5.4%	Revenue: 275706000 Open source Revenue: 261595000 Open source
20152015-12-31	Year over year	4.3%	Revenue: 287458000 Open source Revenue: 275706000 Open source
20162016-12-31	Year over year	14.1%	Revenue: 327868000 Open source Revenue: 287458000 Open source
20172017-12-31	Year over year	3.9%	Revenue: 340750000 Open source Revenue: 327868000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1.9% 2017

Net margin -1.1% 2017

Free cash flow margin 5.1% 2017

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Operating margin	3.6%	Operating Income: 8434000 Open source Revenue: 235173000 Open source
20132013-12-31	Operating margin	-4.5%	Operating Income: -11832000 Open source Revenue: 261595000 Open source
20142014-12-31	Operating margin	-8.6%	Operating Income: -23627000 Open source Revenue: 275706000 Open source
20152015-12-31	Operating margin	-11.8%	Operating Income: -34027000 Open source Revenue: 287458000 Open source
20162016-12-31	Operating margin	-4.7%	Operating Income: -15432000 Open source Revenue: 327868000 Open source
20172017-12-31	Operating margin	-1.9%	Operating Income: -6450000 Open source Revenue: 340750000 Open source
2012-12-31	Net margin	Not reported	Revenue: 235173000 Open source
2013-12-31	Net margin	Not reported	Revenue: 261595000 Open source
2014-12-31	Net margin	Not reported	Revenue: 275706000 Open source
20152015-12-31	Net margin	-11.6%	Net Income: -33308000 Open source Revenue: 287458000 Open source
20162016-12-31	Net margin	-4.2%	Net Income: -13919000 Open source Revenue: 327868000 Open source
20172017-12-31	Net margin	-1.1%	Net Income: -3857000 Open source Revenue: 340750000 Open source
20122012-12-31	Free cash flow margin	6.8%	Revenue: 235173000 Open source Operating Cash Flow: 25962000 Open source Capital Expenditure: 10056000 Open source
20132013-12-31	Free cash flow margin	-0.9%	Revenue: 261595000 Open source Operating Cash Flow: 8552000 Open source Capital Expenditure: 11008000 Open source
20142014-12-31	Free cash flow margin	-3%	Revenue: 275706000 Open source Operating Cash Flow: 2287000 Open source Capital Expenditure: 10455000 Open source
20152015-12-31	Free cash flow margin	-12.3%	Revenue: 287458000 Open source Operating Cash Flow: -11831000 Open source Capital Expenditure: 23483000 Open source
20162016-12-31	Free cash flow margin	-1.9%	Revenue: 327868000 Open source Operating Cash Flow: 13450000 Open source Capital Expenditure: 19786000 Open source
20172017-12-31	Free cash flow margin	5.1%	Revenue: 340750000 Open source Operating Cash Flow: 30602000 Open source Capital Expenditure: 13276000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit12 30.6M 2017

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20122012-12-31	Operating cash flow	25962000	Operating Cash Flow: 25962000 Open source
20132013-12-31	Operating cash flow	8552000	Operating Cash Flow: 8552000 Open source
20142014-12-31	Operating cash flow	2287000	Operating Cash Flow: 2287000 Open source
20152015-12-31	Operating cash flow	-11831000	Operating Cash Flow: -11831000 Open source
20162016-12-31	Operating cash flow	13450000	Operating Cash Flow: 13450000 Open source
20172017-12-31	Operating cash flow	30602000	Operating Cash Flow: 30602000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit12 17.3M 2017

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20122012-12-31	Free cash flow	15906000	Operating Cash Flow: 25962000 Open source Capital Expenditure: 10056000 Open source
20132013-12-31	Free cash flow	-2456000	Operating Cash Flow: 8552000 Open source Capital Expenditure: 11008000 Open source
20142014-12-31	Free cash flow	-8168000	Operating Cash Flow: 2287000 Open source Capital Expenditure: 10455000 Open source
20152015-12-31	Free cash flow	-35314000	Operating Cash Flow: -11831000 Open source Capital Expenditure: 23483000 Open source
20162016-12-31	Free cash flow	-6336000	Operating Cash Flow: 13450000 Open source Capital Expenditure: 19786000 Open source
20172017-12-31	Free cash flow	17326000	Operating Cash Flow: 30602000 Open source Capital Expenditure: 13276000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2012-12-31	Liabilities / assets	Not reported	No source recorded
2013-12-31	Liabilities / assets	Not reported	Total Assets: 177034000 Open source
2014-12-31	Liabilities / assets	Not reported	Total Assets: 185921000 Open source
2015-12-31	Liabilities / assets	Not reported	Total Assets: 184617000 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 201114000 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 231617000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.41× 2017

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2012-12-31	Current assets / current liabilities	Not reported	No source recorded
20132013-12-31	Current assets / current liabilities	4.86×	Current Assets: 144992000 Open source Current Liabilities: 29832000 Open source
20142014-12-31	Current assets / current liabilities	3.87×	Current Assets: 148520000 Open source Current Liabilities: 38338000 Open source
20152015-12-31	Current assets / current liabilities	3.35×	Current Assets: 142950000 Open source Current Liabilities: 42672000 Open source
20162016-12-31	Current assets / current liabilities	3.54×	Current Assets: 145964000 Open source Current Liabilities: 41175000 Open source
20172017-12-31	Current assets / current liabilities	4.41×	Current Assets: 174260000 Open source Current Liabilities: 39516000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2012 2012-01-01 – 2012-12-31	Unavailable Not reported for this period.	Unit12 25.96 million Exact value Exact value: 25962000 Unit12 2012-01-01 – 2012-12-31: 25962000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC HEALTH, INC. · 2012-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Operating Cash Flow: 25962000 Unit12 Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 25962000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837015000335/ghdx-20141231.xml#1100439 Filing: 000155837015000335 The citation records this snapshot. The page link may show a newer release later.	Unit12 10.06 million Exact value Exact value: 10056000 Unit12 2012-01-01 – 2012-12-31: 10056000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC HEALTH, INC. · 2012-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Capital Expenditure: 10056000 Unit12 Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 10056000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837015000335/ghdx-20141231.xml#1169745 Filing: 000155837015000335 The citation records this snapshot. The page link may show a newer release later.	Unit12 15.91 million Calculation and evidence 25962000 − 10056000 Unit12 Exact free cash flow: 15906000 Unit12 2012-01-01 – 2012-12-31: 25962000 Unit12 · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 10056000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC HEALTH, INC. · 2012-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Free cash flow: 15906000 Unit12 Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 25962000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837015000335/ghdx-20141231.xml#1100439 Filing: 000155837015000335 Input fundies:CapitalExpenditure: 10056000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837015000335/ghdx-20141231.xml#1169745 Filing: 000155837015000335 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	Unavailable Not reported for this period.	Unit12 8.55 million Exact value Exact value: 8552000 Unit12 2013-01-01 – 2013-12-31: 8552000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC HEALTH, INC. · 2013-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Operating Cash Flow: 8552000 Unit12 Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 8552000 Unit12 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837016003944/ghdx-20151231.xml#1143634 Filing: 000155837016003944 The citation records this snapshot. The page link may show a newer release later.	Unit12 11.01 million Exact value Exact value: 11008000 Unit12 2013-01-01 – 2013-12-31: 11008000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC HEALTH, INC. · 2013-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Capital Expenditure: 11008000 Unit12 Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 11008000 Unit12 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837016003944/ghdx-20151231.xml#1226403 Filing: 000155837016003944 The citation records this snapshot. The page link may show a newer release later.	−Unit12 2.46 million Calculation and evidence 8552000 − 11008000 Unit12 Exact free cash flow: -2456000 Unit12 2013-01-01 – 2013-12-31: 8552000 Unit12 · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 11008000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC HEALTH, INC. · 2013-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Free cash flow: -2456000 Unit12 Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8552000 Unit12 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837016003944/ghdx-20151231.xml#1143634 Filing: 000155837016003944 Input fundies:CapitalExpenditure: 11008000 Unit12 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837016003944/ghdx-20151231.xml#1226403 Filing: 000155837016003944 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	Unavailable Not reported for this period.	Unit12 2.29 million Exact value Exact value: 2287000 Unit12 2014-01-01 – 2014-12-31: 2287000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC HEALTH, INC. · 2014-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Operating Cash Flow: 2287000 Unit12 Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 2287000 Unit12 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837017001836/ghdx-20161231.xml#1132737 Filing: 000155837017001836 The citation records this snapshot. The page link may show a newer release later.	Unit12 10.46 million Exact value Exact value: 10455000 Unit12 2014-01-01 – 2014-12-31: 10455000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC HEALTH, INC. · 2014-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Capital Expenditure: 10455000 Unit12 Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 10455000 Unit12 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837017001836/ghdx-20161231.xml#1207618 Filing: 000155837017001836 The citation records this snapshot. The page link may show a newer release later.	−Unit12 8.17 million Calculation and evidence 2287000 − 10455000 Unit12 Exact free cash flow: -8168000 Unit12 2014-01-01 – 2014-12-31: 2287000 Unit12 · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 10455000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC HEALTH, INC. · 2014-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Free cash flow: -8168000 Unit12 Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2287000 Unit12 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837017001836/ghdx-20161231.xml#1132737 Filing: 000155837017001836 Input fundies:CapitalExpenditure: 10455000 Unit12 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837017001836/ghdx-20161231.xml#1207618 Filing: 000155837017001836 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−Unit12 33.31 million Exact value Exact value: -33308000 Unit12 2015-01-01 – 2015-12-31: -33308000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · GENOMIC HEALTH, INC. · 2015-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Net Income: -33308000 Unit12 Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -33308000 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837018002061/ghdx-20171231.xml#1201360 Filing: 000155837018002061 The citation records this snapshot. The page link may show a newer release later.	−Unit12 11.83 million Exact value Exact value: -11831000 Unit12 2015-01-01 – 2015-12-31: -11831000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC HEALTH, INC. · 2015-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Operating Cash Flow: -11831000 Unit12 Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -11831000 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837018002061/ghdx-20171231.xml#1200783 Filing: 000155837018002061 The citation records this snapshot. The page link may show a newer release later.	Unit12 23.48 million Exact value Exact value: 23483000 Unit12 2015-01-01 – 2015-12-31: 23483000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC HEALTH, INC. · 2015-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Capital Expenditure: 23483000 Unit12 Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 23483000 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837018002061/ghdx-20171231.xml#1290955 Filing: 000155837018002061 The citation records this snapshot. The page link may show a newer release later.	−Unit12 35.31 million Calculation and evidence -11831000 − 23483000 Unit12 Exact free cash flow: -35314000 Unit12 2015-01-01 – 2015-12-31: -11831000 Unit12 · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 23483000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC HEALTH, INC. · 2015-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Free cash flow: -35314000 Unit12 Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11831000 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837018002061/ghdx-20171231.xml#1200783 Filing: 000155837018002061 Input fundies:CapitalExpenditure: 23483000 Unit12 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837018002061/ghdx-20171231.xml#1290955 Filing: 000155837018002061 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−Unit12 13.92 million Exact value Exact value: -13919000 Unit12 2016-01-01 – 2016-12-31: -13919000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · GENOMIC HEALTH, INC. · 2016-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Net Income: -13919000 Unit12 Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -13919000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1557916 Filing: 000155837019001300 The citation records this snapshot. The page link may show a newer release later.	Unit12 13.45 million Exact value Exact value: 13450000 Unit12 2016-01-01 – 2016-12-31: 13450000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC HEALTH, INC. · 2016-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Operating Cash Flow: 13450000 Unit12 Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 13450000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1557070 Filing: 000155837019001300 The citation records this snapshot. The page link may show a newer release later.	Unit12 19.79 million Exact value Exact value: 19786000 Unit12 2016-01-01 – 2016-12-31: 19786000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC HEALTH, INC. · 2016-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Capital Expenditure: 19786000 Unit12 Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 19786000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1647938 Filing: 000155837019001300 The citation records this snapshot. The page link may show a newer release later.	−Unit12 6.34 million Calculation and evidence 13450000 − 19786000 Unit12 Exact free cash flow: -6336000 Unit12 2016-01-01 – 2016-12-31: 13450000 Unit12 · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 19786000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC HEALTH, INC. · 2016-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Free cash flow: -6336000 Unit12 Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 13450000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1557070 Filing: 000155837019001300 Input fundies:CapitalExpenditure: 19786000 Unit12 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1647938 Filing: 000155837019001300 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−Unit12 3.86 million Exact value Exact value: -3857000 Unit12 2017-01-01 – 2017-12-31: -3857000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · GENOMIC HEALTH, INC. · 2017-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Net Income: -3857000 Unit12 Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -3857000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1558655 Filing: 000155837019001300 The citation records this snapshot. The page link may show a newer release later.	Unit12 30.6 million Exact value Exact value: 30602000 Unit12 2017-01-01 – 2017-12-31: 30602000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC HEALTH, INC. · 2017-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Operating Cash Flow: 30602000 Unit12 Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 30602000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1557262 Filing: 000155837019001300 The citation records this snapshot. The page link may show a newer release later.	Unit12 13.28 million Exact value Exact value: 13276000 Unit12 2017-01-01 – 2017-12-31: 13276000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC HEALTH, INC. · 2017-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Capital Expenditure: 13276000 Unit12 Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 13276000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1648130 Filing: 000155837019001300 The citation records this snapshot. The page link may show a newer release later.	Unit12 17.33 million Calculation and evidence 30602000 − 13276000 Unit12 Exact free cash flow: 17326000 Unit12 2017-01-01 – 2017-12-31: 30602000 Unit12 · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 13276000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC HEALTH, INC. · 2017-12-31 GENOMIC HEALTH, INC. (edgar:1131324) Free cash flow: 17326000 Unit12 Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1131324?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 30602000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1557262 Filing: 000155837019001300 Input fundies:CapitalExpenditure: 13276000 Unit12 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1131324/000155837019001300/ghdx-20181231.xml#1648130 Filing: 000155837019001300 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

69 filings · 2,876 latest values · 2,876 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001131324, 1131324, GHDX, edgar:1131324

Also known as GENOMIC HEALTH INC, GENOMIC HEALTH, INC., GENOMIC HEALTH, INC

GENOMIC HEALTH, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2017 2017-01-01 – 2017-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation